Remodeling of Cardiomyocytes: Study of Morphological Cellular Changes Preceding Symptomatic Ischemic Heart Failure

Milda Kuprytė1, Vaiva Lesauskaitė2, Vytenis Keturakis1

  • 1Laboratory of Cardiac Pathology, Institute of Cardiology, Lithuanian University of Health Sciences, LT-44307 Kaunas, Lithuania.

Insights

Early structural changes in heart muscle cells (cardiomyocytes) and their internal scaffolding occur before symptomatic ischemic heart failure (HF). These remodeling events involve significant alterations in size, shape, and desmin expression, offering insights into HF pathogenesis.

Area of Science:

  • Cardiovascular Biology
  • Cellular Morphology
  • Pathophysiology

Background:

  • Heart failure (HF) pathogenesis mechanisms are known, but early cardiomyocyte changes preceding symptoms are unclear.
  • Understanding early structural cardiomyocyte remodeling is crucial for identifying therapeutic targets in ischemic HF.

Purpose of the Study:

  • To characterize morphological changes in cardiomyocytes.
  • To investigate intermediate filament reorganization during preclinical ischemic heart failure.
  • To analyze desmin expression in relation to HF stages.

Main Methods:

  • Histomorphometric and immunohistochemical analysis of 84 human heart tissue samples.
  • Evaluation of cardiomyocyte size, shape, and desmin expression.
  • Categorization of samples into ACC/AHA HF Stages A, B, and C/D.

Main Results:

  • Cardiomyocyte size and volume increased significantly from Stage A HF, primarily in diameter, and further in Stage C/D HF, mainly in length.
  • Desmin expression elevated in Stage A HF and peaked in Stages C/D HF.
  • Significant cardiomyocyte morphological changes and cytoskeletal reorganization precede symptomatic ischemic HF.

Conclusions:

  • Early, adaptive structural changes in cardiomyocytes and their cytoskeletal network are evident before symptomatic ischemic heart failure.
  • These findings highlight the importance of early cellular remodeling in HF development.
  • Characterization of these preclinical changes provides a foundation for future diagnostic and therapeutic strategies.

Related Concept Videos

Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
14
Myocarditis I: Introduction01:21

Myocarditis I: Introduction

Myocarditis is inflammation of the myocardium, which is the muscular layer of the heart.EtiologyMyocarditis has a diverse etiology, including a wide range of infectious and non-infectious causes:Infectious CausesViral: Common viruses include Coxsackie A and B, adenovirus, parvovirus B19, enteroviruses, and influenza A.Bacterial: Examples include infections caused by Streptococcus, Staphylococcus, and Mycoplasma species.Rickettsial: Infections like Rocky Mountain spotted fever can result in...
9
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
14
Pathophysiology of Heart Failure01:17

Pathophysiology of Heart Failure

Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
1.6K
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
16
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
11